Chr	Start	End	Ref	Alt	Func.refGene	Gene.refGene	GeneDetail.refGene	ExonicFunc.refGene	AAChange.refGene	pLi.refGene	pRec.refGene	pNull.refGene	Disease_description.refGene	P(HI).refGene	P(rec).refGene	RVIS.refGene	RVIS_percentile.refGene	GDI.refGene	GDI-Phred.refGene	SIFT_score	SIFT_converted_rankscore	SIFT_pred	Polyphen2_HDIV_score	Polyphen2_HDIV_rankscore	Polyphen2_HDIV_pred	Polyphen2_HVAR_score	Polyphen2_HVAR_rankscore	Polyphen2_HVAR_pred	LRT_score	LRT_converted_rankscore	LRT_pred	MutationTaster_score	MutationTaster_converted_rankscore	MutationTaster_pred	MutationAssessor_score	MutationAssessor_score_rankscore	MutationAssessor_pred	FATHMM_score	FATHMM_converted_rankscore	FATHMM_pred	PROVEAN_score	PROVEAN_converted_rankscore	PROVEAN_pred	VEST3_score	VEST3_rankscore	MetaSVM_score	MetaSVM_rankscore	MetaSVM_pred	MetaLR_score	MetaLR_rankscore	MetaLR_pred	M-CAP_score	M-CAP_rankscore	M-CAP_pred	CADD_raw	CADD_raw_rankscore	CADD_phred	DANN_score	DANN_rankscore	fathmm-MKL_coding_score	fathmm-MKL_coding_rankscore	fathmm-MKL_coding_pred	Eigen_coding_or_noncoding	Eigen-raw	Eigen-PC-raw	GenoCanyon_score	GenoCanyon_score_rankscore	integrated_fitCons_score	integrated_fitCons_score_rankscore	integrated_confidence_value	GERP++_RS	GERP++_RS_rankscore	phyloP100way_vertebrate	phyloP100way_vertebrate_rankscore	phyloP20way_mammalian	phyloP20way_mammalian_rankscore	phastCons100way_vertebrate	phastCons100way_vertebrate_rankscore	phastCons20way_mammalian	phastCons20way_mammalian_rankscore	SiPhy_29way_logOdds	SiPhy_29way_logOdds_rankscore	Interpro_domain	GTEx_V6_gene	GTEx_V6_tissue	Otherinfo
chr1	13183578	13183578	G	C	exonic	HNRNPCL2	.	nonsynonymous SNV	HNRNPCL2:NM_001136561:exon2:c.C295G:p.R99G	.	.	.	.	.	.	.	.	.	.	.	.	.	0.927	0.495	P	0.593	0.487	P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.385	0.445	.	.	.	.	.	.	.	.	.	-0.206	0.076	1.067	0.496	0.042	0.055	0.112	N	n	-0.273	0.267	0.000	0.055	0.294	0.042	0	0.149	0.141	-0.029	0.122	-0.877	0.028	0.004	0.165	0.004	0.083	6.015	0.187	.	.	.	0.5	99	35	chr1	13183578	chr1:13183578	G	C	99	PASS	AN=2;DP=35	GT	0/1
chr1	15766746	15766746	G	A	intronic	CTRC	.	.	.	5.22E-06	0.4231791	0.57681568	.	0.35475	.	0.016664174	55.21939137	145.59143	2.62957	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	92	chr1	15766746	chr1:15766746	G	A	96	PASS	AN=2;DP=92	GT	0/1
chr1	16975278	16975278	-	C	ncRNA_exonic	MST1P2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	105	chr1	16975278	chr1:16975278	A	AC	92	PASS	AN=2;DP=105	GT	0/1
chr1	17029345	17029345	G	A	ncRNA_exonic	ESPNP	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	97	chr1	17029345	chr1:17029345	G	A	62	PASS	AN=2;DP=97	GT	0/1
chr1	20671961	20671961	G	A	exonic	VWA5B1	.	nonsynonymous SNV	VWA5B1:NM_001039500:exon17:c.G2639A:p.R880H	.	.	.	.	.	.	.	.	7561.17588	18.64813	0.007	0.721	D	1.0	0.899	D	0.991	0.916	D	0.000	0.559	D	0.070	0.369	P	2.55	0.747	M	3.01	0.091	T	-3.14	0.640	D	0.16	0.341	-0.900	0.481	T	0.000	0.000	T	.	.	.	7.077	0.941	33	0.999	0.996	0.947	0.619	D	c	0.678	0.673	0.524	0.211	0.554	0.246	0	5.28	0.740	5.958	0.698	0.988	0.601	1.000	0.715	0.985	0.512	16.390	0.833	.	.	.	0.5	74	28	chr1	20671961	chr1:20671961	G	A	74	PASS	AN=2;DP=28	GT	0/1
chr1	22030121	22030121	A	-	intronic	USP48	.	.	.	0.999997429	2.57E-06	2.13E-16	.	0.10091	0.10216	-0.556537043	19.72753008	115.55589	2.33734	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	63	13	chr1	22030120	chr1:22030120	GA	G	63	PASS	AN=2;DP=13	GT	0/1
chr1	27732202	27732202	G	A	UTR3	WASF2	NM_006990:c.*2481C>T;NM_001201404:c.*2617C>T	.	.	0.975317446	0.024677097	5.46E-06	.	0.44161	0.18052	-0.003562597	53.72729417	54.35937	1.47373	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	74	chr1	27732202	chr1:27732202	G	A	60	PASS	AN=2;DP=74	GT	0/1
chr1	68628198	68628198	A	G	ncRNA_intronic	GNG12-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	18	chr1	68628198	chr1:68628198	A	G	54	PASS	AN=2;DP=18	GT	0/1
chr1	145281613	145281613	C	A	exonic	NOTCH2NL	.	nonsynonymous SNV	NOTCH2NL:NM_203458:exon4:c.C543A:p.S181R	0.000100623	0.575070489	0.424828889	.	0.13774	.	0.657836546	84.27105449	3.00594	0.10883	.	.	.	0.879	0.571	P	0.55	0.621	P	.	.	.	0.999	0.212	N	0.475	0.132	N	1.16	0.381	T	.	.	.	0.366	0.427	-1.068	0.099	T	0.055	0.233	T	.	.	.	3.420	0.469	23.0	0.990	0.502	0.417	0.265	N	c	-0.438	-0.609	1.000	0.747	0.675	0.547	0	0.902	0.183	-0.466	0.067	0.622	0.289	0.000	0.063	0.679	0.305	6.588	0.217	.	.	.	0.5	89	86	chr1	145281613	chr1:145281613	C	A	89	PASS	AN=2;DP=86	GT	0/1
chr1	145281633	145281633	C	A	exonic	NOTCH2NL	.	nonsynonymous SNV	NOTCH2NL:NM_203458:exon4:c.C563A:p.P188H	0.000100623	0.575070489	0.424828889	.	0.13774	.	0.657836546	84.27105449	3.00594	0.10883	.	.	.	0.998	0.899	D	0.912	0.701	D	.	.	.	0.910	0.364	D	2.59	0.760	M	2.86	0.105	T	.	.	.	0.513	0.556	-1.112	0.029	T	0.051	0.217	T	.	.	.	5.957	0.818	27.7	0.995	0.677	0.969	0.712	D	c	0.519	0.389	1.0	0.983	0.675	0.547	0	2.87	0.324	7.735	0.838	0.622	0.289	1.000	0.715	0.990	0.544	11.536	0.497	EGF-like domain	.	.	0.5	85	85	chr1	145281633	chr1:145281633	C	A	85	PASS	AN=2;DP=85	GT	0/1
chr1	162748361	162748361	C	T	intronic	DDR2	.	.	.	0.990992372	0.009007624	3.79E-09	DISEASE: Spondyloepimetaphyseal dysplasia short limb-hand type (SEMD-SL) [MIM:271665]: A bone disease characterized by short- limbed dwarfism, a narrow chest with pectus excavatum, brachydactyly in the hands and feet, a characteristic craniofacial appearance and premature calcifications. The radiological findings are distinctive and comprise short long bones throughout the skeleton with striking epiphyses that are stippled, flattened and fragmented and flared, irregular metaphyses. Platyspondyly in the spine with wide intervertebral spaces is observed and some vertebral bodies are pear-shaped with central humps, anterior protrusions and posterior scalloping. {ECO:0000269|PubMed:19110212, ECO:0000269|PubMed:20223752}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.85011	0.1349	-0.775187015	13.05142722	110.07197	2.27991	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	47	chr1	162748361	chr1:162748361	C	T	71	PASS	AN=2;DP=47	GT	0/1
chr2	61644004	61644076	CACAGTGGAAGCCCTCATGAGTGCAGGGCCAGCCACTTGTCCAGAGGGCCATGAATGGCGACATACTTGACCC	-	intronic	USP34	.	.	.	1	4.84E-19	7.26E-51	.	0.83824	0.09517	-3.59020415	0.300778485	689.89772	5.23798	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	61	chr2	61644003	chr2:61644003	GCACAGTGGAAGCCCTCATGAGTGCAGGGCCAGCCACTTGTCCAGAGGGCCATGAATGGCGACATACTTGACCC	G	41	PASS	AN=2;DP=61	GT	0/1
chr2	89326797	89326886	GGATGCATCATAGATGAGGAGCCTGGGAGCCTGGCCAGGTTTCTGTTGGTACCAGGCTAAGTAGCTGCTAACACTCTGACTGGCCCTGCA	-	intergenic	MIR4436A;NONE	dist=214829;dist=NONE	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	47	chr2	89326796	chr2:89326796	TGGATGCATCATAGATGAGGAGCCTGGGAGCCTGGCCAGGTTTCTGTTGGTACCAGGCTAAGTAGCTGCTAACACTCTGACTGGCCCTGCA	T	54	PASS	AN=2;DP=47	GT	0/1
chr2	96504594	96504594	C	T	intergenic	LINC00342;ANKRD36C	dist=11865;dist=10702	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	64	chr2	96504594	chr2:96504594	C	T	64	PASS	AN=2;DP=64	GT	0/1
chr2	112526866	112526866	G	A	UTR3	ANAPC1	NM_022662:c.*2C>T	.	.	.	.	.	.	0.55585	0.09577	.	.	199.72138	3.0527	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	52	55	chr2	112526866	chr2:112526866	G	A	52	PASS	AN=2;DP=55	GT	0/1
chr2	166810161	166810161	-	CCCGCTCA	intronic	TTC21B	.	.	.	3.39E-22	0.098887146	0.901112854	DISEASE: Note=Ciliary dysfunction leads to a broad spectrum of disorders, collectively termed ciliopathies. Overlapping clinical features include retinal degeneration, renal cystic disease, skeletal abnormalities, fibrosis of various organ, and a complex range of anatomical and functional defects of the central and peripheral nervous system. The ciliopathy range of diseases includes Meckel-Gruber syndrome, Bardet-Biedl syndrome, Joubert syndrome, nephronophtisis, Senior-Loken syndrome, and Jeune asphyxiating thoracic dystrophy among others. TTC21B is causally associated with diverse ciliopathies, and also acts as a modifier gene across the ciliopathy spectrum. TTC21B mutations interact in trans with mutations in other ciliopathy-causing genes and contribute to disease manifestation and severity.; DISEASE: Nephronophthisis 12 (NPHP12) [MIM:613820]: An autosomal recessive disorder resulting in end-stage renal disease. It is a progressive tubulo-interstitial kidney disorder histologically characterized by modifications of the tubules with thickening of the basement membrane, interstitial fibrosis and, in the advanced stages, medullary cysts. Some patients manifest extra-renal features including retinal, skeletal and central nervous system defects. {ECO:0000269|PubMed:21258341}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Short-rib thoracic dysplasia 4 with or without polydactyly (SRTD4) [MIM:613819]: A form of short-rib thoracic dysplasia, a group of autosomal recessive ciliopathies that are characterized by a constricted thoracic cage, short ribs, shortened tubular bones, and a 'trident' appearance of the acetabular roof. Polydactyly is variably present. Non-skeletal involvement can include cleft lip/palate as well as anomalies of major organs such as the brain, eye, heart, kidneys, liver, pancreas, intestines, and genitalia. Some forms of the disease are lethal in the neonatal period due to respiratory insufficiency secondary to a severely restricted thoracic cage, whereas others are compatible with life. Disease spectrum encompasses Ellis-van Creveld syndrome, asphyxiating thoracic dystrophy (Jeune syndrome), Mainzer-Saldino syndrome, and short rib-polydactyly syndrome. {ECO:0000269|PubMed:21258341}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Bardet-Biedl syndrome (BBS) [MIM:209900]: A syndrome characterized by usually severe pigmentary retinopathy, early- onset obesity, polydactyly, hypogenitalism, renal malformation and mental retardation. Secondary features include diabetes mellitus, hypertension and congenital heart disease. Bardet-Biedl syndrome inheritance is autosomal recessive, but three mutated alleles (two at one locus, and a third at a second locus) may be required for clinical manifestation of some forms of the disease. {ECO:0000269|PubMed:21258341}. Note=The disease may be caused by mutations affecting the gene represented in this entry.; DISEASE: Joubert syndrome 11 (JBTS11) [MIM:613820]: A disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy and renal disease. {ECO:0000269|PubMed:21258341, ECO:0000269|PubMed:22425360}. Note=The disease may be caused by mutations affecting the gene represented in this entry.; 	0.13531	0.09894	0.619029743	83.25666431	820.66154	5.62646	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	33	chr2	166810161	chr2:166810161	G	GCCCGCTCA	66	PASS	AN=2;DP=33	GT	0/1
chr2	210368990	210368990	-	A	intronic	MAP2	.	.	.	0.999983365	1.66E-05	9.93E-14	.	0.28644	0.25532	-1.313764723	4.824251003	424.49113	4.30507	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	15	chr2	210368990	chr2:210368990	T	TA	69	PASS	AN=2;DP=15	GT	0/1
chr2	228735140	228735140	T	C	upstream	DAW1	dist=952	.	.	0.000785948	0.982644868	0.016569184	.	0.08054	0.09429	0.440999548	77.79547063	1957.37654	8.14493	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	45	12	chr2	228735140	chr2:228735140	T	C	45	PASS	AN=2;DP=12	GT	0/1
chr2	228735186	228735186	T	C	upstream	DAW1	dist=906	.	.	0.000785948	0.982644868	0.016569184	.	0.08054	0.09429	0.440999548	77.79547063	1957.37654	8.14493	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	45	19	chr2	228735186	chr2:228735186	T	C	45	PASS	AN=2;DP=19	GT	0/1
chr3	9771206	9771206	G	T	exonic	CPNE9	.	unknown	UNKNOWN	0.001032103	0.998871292	9.66E-05	.	0.25543	.	0.084621747	60.31493277	44.06764	1.26466	0.002	0.721	D	0.999	0.764	D	0.98	0.732	D	0.000	0.843	U	1	0.810	D	3.585	0.937	H	3.26	0.067	T	-6.11	0.900	D	0.935	0.929	-0.783	0.562	T	0.112	0.402	T	0.081	0.737	D	6.948	0.934	33	0.994	0.637	0.995	0.965	D	c	0.977	0.896	1.000	0.747	0.626	0.397	0	4.99	0.658	9.589	0.974	0.953	0.551	1.000	0.715	1.000	0.888	17.894	0.887	Copine|von Willebrand factor, type A	.	.	0.5	.	30	chr3	9771206	chr3:9771206	G	T	.	PASS	AN=0;DP=30	GT	0/1
chr3	10491147	10491147	T	G	exonic	ATP2B2	.	synonymous SNV	ATP2B2:NM_001001331:exon2:c.A81C:p.T27T,ATP2B2:NM_001330611:exon2:c.A81C:p.T27T,ATP2B2:NM_001683:exon2:c.A81C:p.T27T	0.999921506	7.85E-05	8.79E-13	.	0.69922	0.18045	-1.943881244	1.893135173	96.26442	2.12107	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	46	58	chr3	10491147	chr3:10491147	T	G	46	PASS	AN=2;DP=58	GT	0/1
chr3	75480040	75480041	CA	-	ncRNA_exonic	FAM86DP	.	.	.	.	.	.	.	0.06283	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	77	chr3	75480039	chr3:75480039	TCA	T	62	PASS	AN=2;DP=77	GT	0/1
chr3	195978138	195978138	T	C	intronic	PCYT1A	.	.	.	0.098300076	0.90012567	0.001574255	DISEASE: Spondylometaphyseal dysplasia with cone-rod dystrophy (SMDCRD) [MIM:608940]: A disorder characterized by postnatal growth deficiency resulting in profound short stature, rhizomelia with bowing of the lower extremities, platyspondyly with anterior vertebral protrusions, progressive metaphyseal irregularity and cupping with shortened tubular bones, and early-onset progressive visual impairment associated with a pigmentary maculopathy and electroretinographic evidence of cone-rod dysfunction. {ECO:0000269|PubMed:24387990, ECO:0000269|PubMed:24387991}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.75481	.	-0.846787714	11.05803255	78.82184	1.87555	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	96	97	chr3	195978138	chr3:195978138	T	C	96	PASS	AN=2;DP=97	GT	0/1
chr4	9557816	9557821	AGAAGG	-	ncRNA_exonic	MIR548I2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	35	chr4	9557815	chr4:9557815	TAGAAGG	T	65	PASS	AN=2;DP=35	GT	0/1
chr4	77969239	77969239	-	T	UTR3	CCNI	NM_001348133:c.*132_*133insA;NM_001348132:c.*132_*133insA;NM_001348134:c.*132_*133insA;NM_001348135:c.*132_*133insA;NM_001348136:c.*132_*133insA;NM_001348137:c.*132_*133insA;NM_001348138:c.*132_*133insA;NM_001348139:c.*132_*133insA;NM_001348140:c.*557_*558insA;NM_006835:c.*132_*133insA	.	.	0.789094043	0.209550825	0.001355133	.	0.26347	0.16383	0.104848986	61.49445624	48.69159	1.3608	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	56	27	chr4	77969239	chr4:77969239	A	AT	56	PASS	AN=2;DP=27	GT	0/1
chr4	88813100	88813100	G	A	intergenic	MEPE;SPP1	dist=45132;dist=83702	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	30	chr4	88813100	chr4:88813100	G	A	92	PASS	AN=2;DP=30	GT	0/1
chr4	102072740	102072740	C	T	intronic	PPP3CA	.	.	.	0.998148789	0.001851202	9.61E-09	.	0.91458	0.30319	-0.427900189	25.14744043	6.37885	0.23918	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	57	chr4	102072740	chr4:102072740	C	T	65	PASS	AN=2;DP=57	GT	0/1
chr5	95733110	95733110	-	ATTTTTTTCAAGCAGAAGACGGCATACGAGATTGGTCAGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTTGTGTGAACAGACATGAAGTCCCAATTCTCAAAGTCCAAGTACCTATAGGGTTCTCTCCCCATGTGTGAACAGACATGAAGTCCC	exonic	PCSK1	.	stopgain	PCSK1:NM_000439:exon12:c.1651_1652insGGGACTTCATGTCTGTTCACACATGGGGAGAGAACCCTATAGGTACTTGGACTTTGAGAATTGGGACTTCATGTCTGTTCACACAAGATCGGAAGAGCACACGTCTGAACTCCAGTCACTGACCAATCTCGTATGCCGTCTTCTGCTTGAAAAAAAT:p.T572Gfs*19,PCSK1:NM_001177875:exon12:c.1510_1511insGGGACTTCATGTCTGTTCACACATGGGGAGAGAACCCTATAGGTACTTGGACTTTGAGAATTGGGACTTCATGTCTGTTCACACAAGATCGGAAGAGCACACGTCTGAACTCCAGTCACTGACCAATCTCGTATGCCGTCTTCTGCTTGAAAAAAAT:p.T525Gfs*19	0.089639821	0.910344875	1.53E-05	DISEASE: Proprotein convertase 1 deficiency (PC1 deficiency) [MIM:600955]: Characterized by obesity, hypogonadism, hypoadrenalism, reactive hypoglycemia as well as marked small- intestinal absorptive dysfunction It is due to impaired processing of prohormones. {ECO:0000269|PubMed:14617756, ECO:0000269|PubMed:17595246, ECO:0000269|PubMed:9207799}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.35142	0.33991	-0.420619508	25.72540694	2006.75712	8.2505	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	23	chr5	95733048	chr5:95733048	TAATTCTCAAAGTCCAAGTACCTATAGGGTTCTCTCCCCATGTGTGAACAGACATGAAGTCCC	TAATTCTCAAAGTCCAAGTACCTATAGGGTTCTCTCCCCATGTGTGAACAGACATGAAGTCCCATTTTTTTCAAGCAGAAGACGGCATACGAGATTGGTCAGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTTGTGTGAACAGACATGAAGTCCCAATTCTCAAAGTCCAAGTACCTATAGGGTTCTCTCCCCATGTGTGAACAGACATGAAGTCCC,T	42	PASS	AN=2;DP=23	GT	0/1
chr5	95733049	95733110	AATTCTCAAAGTCCAAGTACCTATAGGGTTCTCTCCCCATGTGTGAACAGACATGAAGTCCC	-	exonic	PCSK1	.	frameshift deletion	PCSK1:NM_000439:exon12:c.1652_1713del:p.W551Yfs*9,PCSK1:NM_001177875:exon12:c.1511_1572del:p.W504Yfs*9	0.089639821	0.910344875	1.53E-05	DISEASE: Proprotein convertase 1 deficiency (PC1 deficiency) [MIM:600955]: Characterized by obesity, hypogonadism, hypoadrenalism, reactive hypoglycemia as well as marked small- intestinal absorptive dysfunction It is due to impaired processing of prohormones. {ECO:0000269|PubMed:14617756, ECO:0000269|PubMed:17595246, ECO:0000269|PubMed:9207799}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.35142	0.33991	-0.420619508	25.72540694	2006.75712	8.2505	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	23	chr5	95733048	chr5:95733048	TAATTCTCAAAGTCCAAGTACCTATAGGGTTCTCTCCCCATGTGTGAACAGACATGAAGTCCC	TAATTCTCAAAGTCCAAGTACCTATAGGGTTCTCTCCCCATGTGTGAACAGACATGAAGTCCCATTTTTTTCAAGCAGAAGACGGCATACGAGATTGGTCAGTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTTGTGTGAACAGACATGAAGTCCCAATTCTCAAAGTCCAAGTACCTATAGGGTTCTCTCCCCATGTGTGAACAGACATGAAGTCCC,T	42	PASS	AN=2;DP=23	GT	0/1
chr5	134041132	134041132	G	A	intronic	SEC24A	.	.	.	1.31E-05	0.999969557	1.73E-05	.	0.19793	0.09969	-1.058182374	7.554847841	248.85929	3.3989	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	63	56	chr5	134041132	chr5:134041132	G	A	63	PASS	AN=2;DP=56	GT	0/1
chr5	139227250	139227250	T	-	UTR3	NRG2	NM_001184935:c.*252delA;NM_004883:c.*252delA;NM_013981:c.*252delA;NM_013982:c.*252delA;NM_013983:c.*252delA	.	.	0.995154288	0.004845611	1.01E-07	.	0.87096	0.14813	.	.	357.16396	4.00512	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	57	21	chr5	139227249	chr5:139227249	CT	C	57	PASS	AN=2;DP=21	GT	0/1
chr5	140516367	140516367	A	T	exonic	PCDHB5	.	nonsynonymous SNV	PCDHB5:NM_015669:exon1:c.A1351T:p.T451S	9.45E-07	0.318857036	0.681142019	.	0.07466	.	0.273728691	70.74781788	486.05983	4.53925	0.209	0.197	T	0.012	0.151	B	0.023	0.188	B	.	.	.	1.000	0.090	N	-0.035	0.050	N	4.16	0.028	T	-3.1	0.635	D	0.068	0.055	-0.888	0.491	T	0.003	0.011	T	.	.	.	-0.483	0.056	0.242	0.814	0.132	0.108	0.160	N	c	-1.077	-0.949	0.002	0.087	0.706	0.609	0	0.773	0.176	-0.393	0.073	0.149	0.237	0.000	0.063	0.953	0.430	5.715	0.171	Cadherin|Cadherin-like	.	.	0.5	60	119	chr5	140516367	chr5:140516367	A	T	60	PASS	AN=2;DP=119	GT	0/1
chr6	3224825	3224825	A	-	UTR3	TUBB2B	NM_178012:c.*160delT	.	.	.	.	.	DISEASE: Polymicrogyria, symmetric or asymmetric (PMGYSA) [MIM:610031]: A malformation of the cortex in which the brain surface is irregular and characterized by an excessive number of small gyri with abnormal lamination. Polymicrogyria is a heterogeneous disorder, considered to be the result of postmigratory abnormal cortical organization. {ECO:0000269|PubMed:19465910}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.72371	0.27035	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	89	21	chr6	3224824	chr6:3224824	GA	G	89	PASS	AN=2;DP=21	GT	0/1
chr6	86349956	86349956	C	T	exonic	SYNCRIP	.	nonsynonymous SNV	SYNCRIP:NM_001159673:exon3:c.G64A:p.D22N,SYNCRIP:NM_001159675:exon3:c.G358A:p.D120N,SYNCRIP:NM_001159676:exon3:c.G358A:p.D120N,SYNCRIP:NM_001159674:exon4:c.G358A:p.D120N,SYNCRIP:NM_001159677:exon4:c.G358A:p.D120N,SYNCRIP:NM_006372:exon4:c.G358A:p.D120N	0.999378591	0.000621405	3.32E-09	.	0.9771	0.24974	-0.560178693	19.30879925	10.81382	0.39248	0.35	0.247	T	0.11	0.532	B	0.05	0.542	B	0.000	0.843	D	1	0.810	D	2.585	0.758	M	1.55	0.301	T	-3.76	0.768	D	0.077	0.080	-1.144	0.012	T	0.068	0.277	T	0.018	0.400	T	3.602	0.490	23.2	0.994	0.644	0.981	0.798	D	c	0.227	0.374	1.0	0.983	0.660	0.490	0	5.42	0.786	6.155	0.714	0.015	0.141	1.000	0.715	1.000	0.888	18.812	0.920	.	.	.	0.5	56	50	chr6	86349956	chr6:86349956	C	T	56	PASS	AN=2;DP=50	GT	0/1
chr6	130504536	130504536	G	A	intronic	SAMD3	.	.	.	1.10E-06	0.937046699	0.062952204	.	0.10152	0.10086	-0.354480518	29.42911064	120.51258	2.39131	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	36	chr6	130504536	chr6:130504536	G	A	55	PASS	AN=2;DP=36	GT	0/1
chr6	148835437	148835437	T	-	intronic	SASH1	.	.	.	0.003254445	0.996741817	3.74E-06	.	0.3689	0.11167	-0.562239385	19.06699693	3939.62918	12.40945	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	83	chr6	148835436	chr6:148835436	CT	C	92	PASS	AN=2;DP=83	GT	0/1
chr6	168439334	168439334	C	G	exonic	KIF25	.	nonsynonymous SNV	KIF25:NM_005355:exon5:c.C419G:p.A140G,KIF25:NM_030615:exon5:c.C419G:p.A140G	3.75E-09	0.098368373	0.901631624	.	0.04864	0.08777	1.936492053	97.50530786	587.48576	4.91639	0.586	0.059	T	0.002	0.090	B	0.004	0.139	B	0.715	0.063	N	1	0.090	N	-0.515	0.026	N	-0.68	0.726	T	0.13	0.055	N	0.063	0.097	-1.043	0.163	T	0.049	0.209	T	0.014	0.346	T	-0.926	0.035	0.023	0.088	0.001	0.012	0.043	N	c	-1.111	-1.079	0.119	0.168	0.646	0.450	0	0.843	0.180	1.421	0.342	-0.166	0.106	0.005	0.169	0.000	0.016	6.239	0.199	Kinesin motor domain|P-loop containing nucleoside triphosphate hydrolase	.	.	0.5	93	82	chr6	168439334	chr6:168439334	C	G	93	PASS	AN=2;DP=82	GT	0/1
chr7	6045627	6045627	C	T	exonic	PMS2	.	nonsynonymous SNV	PMS2:NM_000535:exon2:c.G59A:p.R20Q,PMS2:NM_001322006:exon2:c.G59A:p.R20Q,PMS2:NM_001322014:exon2:c.G59A:p.R20Q	1.14E-13	0.266962097	0.733037903	DISEASE: Hereditary non-polyposis colorectal cancer 4 (HNPCC4) [MIM:614337]: An autosomal dominant disease associated with marked increase in cancer susceptibility. It is characterized by a familial predisposition to early-onset colorectal carcinoma (CRC) and extra-colonic tumors of the gastrointestinal, urological and female reproductive tracts. HNPCC is reported to be the most common form of inherited colorectal cancer in the Western world. Clinically, HNPCC is often divided into two subgroups. Type I is characterized by hereditary predisposition to colorectal cancer, a young age of onset, and carcinoma observed in the proximal colon. Type II is characterized by increased risk for cancers in certain tissues such as the uterus, ovary, breast, stomach, small intestine, skin, and larynx in addition to the colon. Diagnosis of classical HNPCC is based on the Amsterdam criteria: 3 or more relatives affected by colorectal cancer, one a first degree relative of the other two; 2 or more generation affected; 1 or more colorectal cancers presenting before 50 years of age; exclusion of hereditary polyposis syndromes. The term 'suspected HNPCC' or 'incomplete HNPCC' can be used to describe families who do not or only partially fulfill the Amsterdam criteria, but in whom a genetic basis for colon cancer is strongly suspected. {ECO:0000269|PubMed:15887124, ECO:0000269|PubMed:18178629, ECO:0000269|PubMed:23709753}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Mismatch repair cancer syndrome (MMRCS) [MIM:276300]: An autosomal recessive, rare, childhood cancer predisposition syndrome encompassing a broad tumor spectrum. This includes hematological malignancies, central nervous system tumors, Lynch syndrome-associated malignancies such as colorectal tumors as well as multiple intestinal polyps, embryonic tumors and rhabdomyosarcoma. Multiple cafe-au-lait macules, a feature reminiscent of neurofibromatosis type 1, are often found as first manifestation of the underlying cancer. Areas of skin hypopigmentation have also been reported in MMRCS patients. {ECO:0000269|PubMed:15077197, ECO:0000269|PubMed:17557300, ECO:0000269|PubMed:7661930, ECO:0000269|PubMed:9419979}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.7782	.	1.477080431	95.28780373	788.03656	5.54211	0.121	0.277	T	0.857	0.493	P	0.294	0.435	B	0.001	0.419	N	0.614	0.588	P	2.045	0.562	M	-1.77	0.862	D	-1.77	0.446	N	0.039	0.198	-0.606	0.646	T	0.051	0.218	T	.	.	.	2.877	0.406	21.7	0.997	0.780	0.589	0.305	D	c	-0.371	-0.359	0.741	0.232	0.732	0.924	0	0.771	0.176	0.288	0.186	-0.372	0.066	0.939	0.324	0.980	0.490	10.394	0.432	Histidine kinase-like ATPase, C-terminal domain	ENSG00000187953.6|ENSG00000122512.10|ENSG00000122512.10|ENSG00000122512.10|ENSG00000122512.10|ENSG00000122512.10|ENSG00000122512.10|ENSG00000122512.10|ENSG00000122512.10|ENSG00000187953.6|ENSG00000122512.10|ENSG00000122512.10|ENSG00000122512.10	Adipose_Subcutaneous|Adipose_Subcutaneous|Artery_Tibial|Breast_Mammary_Tissue|Esophagus_Mucosa|Lung|Muscle_Skeletal|Nerve_Tibial|Skin_Not_Sun_Exposed_Suprapubic|Skin_Sun_Exposed_Lower_leg|Skin_Sun_Exposed_Lower_leg|Spleen|Thyroid	0.5	85	138	chr7	6045627	chr7:6045627	C	T	85	PASS	AN=2;DP=138	GT	0/1
chr7	56141802	56141802	C	A	intronic	SUMF2	.	.	.	5.53E-05	0.883050597	0.11689414	.	0.07185	0.68732	0.420771676	77.15852795	226.86098	3.25511	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	32	chr7	56141802	chr7:56141802	C	A	.	PASS	AN=0;DP=32	GT	0/1
chr7	86548597	86548597	T	C	exonic	KIAA1324L	.	nonsynonymous SNV	KIAA1324L:NM_001291991:exon10:c.A709G:p.S237G,KIAA1324L:NM_152748:exon10:c.A928G:p.S310G,KIAA1324L:NM_001142749:exon11:c.A1429G:p.S477G,KIAA1324L:NM_001291990:exon11:c.A1087G:p.S363G	0.000166955	0.998513153	0.001319892	.	0.42256	.	-0.396754488	26.97570182	453.25685	4.43012	0.002	0.784	D	0.985	0.615	D	0.81	0.572	P	0.000	0.843	D	1	0.810	D	2.765	0.810	M	0.96	0.429	T	-3.35	0.664	D	0.748	0.747	-0.778	0.564	T	0.205	0.564	T	0.010	0.257	T	5.387	0.730	26.0	0.998	0.885	0.966	0.695	D	c	0.636	0.657	0.998	0.357	0.706	0.609	0	6.08	0.990	3.958	0.562	1.057	0.759	1.000	0.715	1.000	0.888	15.824	0.784	Growth factor receptor cysteine-rich domain	.	.	0.5	60	55	chr7	86548597	chr7:86548597	T	C	60	PASS	AN=2;DP=55	GT	0/1
chr7	151945167	151945167	G	T	exonic	KMT2C	.	synonymous SNV	KMT2C:NM_170606:exon14:c.C2352A:p.S784S	1	2.53E-15	2.34E-47	.	0.46876	0.10649	-2.516369113	0.908233074	8094.45636	19.4302	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	58	chr7	151945167	chr7:151945167	G	T	50	PASS	AN=2;DP=58	GT	0/1
chr8	169305	169305	G	C	ncRNA_exonic	RPL23AP53	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	48	66	chr8	169305	chr8:169305	G	C	48	PASS	AN=2;DP=66	GT	0/1
chr8	11142389	11142389	-	G	UTR5	MTMR9	NM_015458:c.-9_-8insG	.	.	0.210866149	0.789056594	7.73E-05	.	0.09655	0.1143	-0.819281839	11.93677754	192.38541	3.00675	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	63	14	chr8	11142389	chr8:11142389	C	CG	63	PASS	AN=2;DP=14	GT	0/1
chr8	11872395	11872395	A	G	intergenic	DEFB134;DEFB130B	dist=14134;dist=49503	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	63	43	chr8	11872395	chr8:11872395	A	G	63	PASS	AN=2;DP=43	GT	0/1
chr8	25287397	25287397	T	C	exonic	KCTD9	.	synonymous SNV	KCTD9:NM_017634:exon12:c.A1146G:p.L382L	0.073396831	0.926083873	0.000519296	.	0.10831	0.11262	-0.117432389	44.89266336	12.22101	0.44285	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	25	chr8	25287397	chr8:25287397	T	C	81	PASS	AN=2;DP=25	GT	0/1
chr8	144641688	144641688	C	G	exonic	GSDMD	.	nonsynonymous SNV	GSDMD:NM_024736:exon2:c.C183G:p.I61M,GSDMD:NM_001166237:exon5:c.C183G:p.I61M	4.81E-07	0.393297033	0.606702486	.	0.06547	0.09123	-0.086288664	47.11606511	230.01248	3.27773	0.019	0.512	D	1.0	0.899	D	0.996	0.832	D	0.001	0.400	N	0.896	0.278	N	2.34	0.674	M	1.7	0.269	T	-1.55	0.404	N	0.502	0.582	-0.954	0.403	T	0.148	0.473	T	0.026	0.491	D	5.188	0.700	25.5	0.997	0.785	0.508	0.285	D	c	0.454	0.341	1.000	0.747	0.696	0.567	0	3.98	0.452	2.629	0.459	0.843	0.344	0.034	0.205	0.998	0.697	9.211	0.363	.	.	.	0.5	60	54	chr8	144641688	chr8:144641688	C	G	60	PASS	AN=2;DP=54	GT	0/1
chr8	145234350	145234350	C	T	intronic	MROH1	.	.	.	0.587142255	0.412416428	0.000441317	.	.	.	.	.	77.45123	1.85066	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	55	chr8	145234350	chr8:145234350	C	T	64	PASS	AN=2;DP=55	GT	0/1
chr9	139650595	139650595	T	G	intronic	LCN8	.	.	.	0.042675812	0.847352111	0.109972077	.	0.03683	.	0.373041938	75.29488087	1010.88949	6.12169	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	116	chr9	139650595	chr9:139650595	T	G	74	PASS	AN=2;DP=116	GT	0/1
chr10	129903016	129903016	T	C	exonic	MKI67	.	nonsynonymous SNV	MKI67:NM_001145966:exon12:c.A6008G:p.N2003S,MKI67:NM_002417:exon13:c.A7088G:p.N2363S	4.17E-16	0.998663439	0.001336561	.	0.62381	.	7.633856952	99.91153574	13447.4791	25.13173	0.961	0.025	T	0.0	0.026	B	0.0	0.013	B	0.000	0.005	N	1	0.090	P	-1.905	0.002	N	4.72	0.017	T	0.46	0.031	N	0.004	0.000	-0.936	0.433	T	0.000	0.000	T	.	.	.	-2.735	0.002	0.001	0.198	0.007	0.043	0.097	N	c	-2.051	-2.056	1.000	0.428	0.707	0.730	0	-5.36	0.025	-0.267	0.086	-2.064	0.005	0.000	0.063	0.000	0.016	9.392	0.374	.	.	.	0.5	62	52	chr10	129903016	chr10:129903016	T	C	62	PASS	AN=2;DP=52	GT	0/1
chr11	1264890	1264890	A	G	exonic	MUC5B	.	synonymous SNV	MUC5B:NM_002458:exon31:c.A6780G:p.R2260R	0.999999706	2.94E-07	6.12E-25	DISEASE: Pulmonary fibrosis, idiopathic (IPF) [MIM:178500]: A lung disease characterized by shortness of breath, radiographically evident diffuse pulmonary infiltrates, and varying degrees of inflammation and fibrosis on biopsy. In some cases, the disorder can be rapidly progressive and characterized by sequential acute lung injury with subsequent scarring and end-stage lung disease. {ECO:0000269|PubMed:21506741, ECO:0000269|PubMed:21506748}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. A common polymorphism in the promoter of MUC5B is associated with familial interstitial pneumonia and idiopathic pulmonary fibrosis, suggesting that dysregulated MUC5B expression in the lung may be involved in the pathogenesis of pulmonary fibrosis (PubMed:21506741). {ECO:0000269|PubMed:21506741}.; 	0.07831	.	16.52445195	99.97640953	6531.39188	16.99148	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	107	chr11	1264890	chr11:1264890	A	G	69	PASS	AN=2;DP=107	GT	0/1
chr11	4351584	4351584	C	A	intergenic	LOC100506082;OR52B4	dist=127701;dist=36909	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	42	chr11	4351584	chr11:4351584	C	A	81	PASS	AN=2;DP=42	GT	0/1
chr11	6561270	6561270	A	G	exonic	DNHD1	.	synonymous SNV	DNHD1:NM_144666:exon18:c.A3585G:p.Q1195Q	1.33E-18	0.411356392	0.588643608	.	0.08316	.	6.676327134	99.88204765	15349.22988	26.78541	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	24	chr11	6561270	chr11:6561270	A	G	44	PASS	AN=2;DP=24	GT	0/1
chr11	61507049	61507049	C	T	exonic	DAGLA	.	nonsynonymous SNV	DAGLA:NM_006133:exon17:c.C1769T:p.T590I	0.953148342	0.046851612	4.51E-08	.	0.39271	0.11988	-0.573127851	18.96083982	278.59856	3.57787	0.062	0.369	T	0.838	0.444	P	0.446	0.442	B	0.000	0.843	D	1.000	0.530	D	1.245	0.315	L	1.78	0.257	T	-2.31	0.513	N	0.21	0.258	-1.064	0.108	T	0.072	0.294	T	0.017	0.380	T	3.874	0.522	23.5	0.994	0.608	0.923	0.550	D	c	0.254	0.257	1.000	0.517	0.651	0.465	0	4.23	0.492	6.038	0.704	0.852	0.362	1.000	0.715	0.822	0.344	17.000	0.862	.	.	.	0.5	78	110	chr11	61507049	chr11:61507049	C	T	78	PASS	AN=2;DP=110	GT	0/1
chr11	130059634	130059634	C	T	exonic	ST14	.	synonymous SNV	ST14:NM_021978:exon5:c.C441T:p.S147S	0.852676553	0.147322586	8.62E-07	DISEASE: Ichthyosis, congenital, autosomal recessive 11 (ARCI11) [MIM:602400]: A form of autosomal recessive congenital ichthyosis, a disorder of keratinization with abnormal differentiation and desquamation of the epidermis, resulting in abnormal skin scaling over the whole body. The main skin phenotypes are lamellar ichthyosis (LI) and non-bullous congenital ichthyosiform erythroderma (NCIE), although phenotypic overlap within the same patient or among patients from the same family can occur. Lamellar ichthyosis is a condition often associated with an embedment in a collodion-like membrane at birth; skin scales later develop, covering the entire body surface. Non-bullous congenital ichthyosiform erythroderma characterized by fine whitish scaling on an erythrodermal background; larger brownish scales are present on the buttocks, neck and legs. {ECO:0000269|PubMed:17273967, ECO:0000269|PubMed:18843291}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.43903	0.33644	-0.347208386	29.59424393	1268.8342	6.71293	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	42	chr11	130059634	chr11:130059634	C	T	72	PASS	AN=2;DP=42	GT	0/1
chr12	8082367	8082367	T	C	exonic	SLC2A3	.	synonymous SNV	SLC2A3:NM_006931:exon6:c.A774G:p.L258L	0.519822946	0.47941858	0.000758474	.	0.35764	0.14971	0.619191319	83.36282142	55.14143	1.4881	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	61	chr12	8082367	chr12:8082367	T	C	66	PASS	AN=2;DP=61	GT	0/1
chr12	11546686	11546686	C	T	exonic	PRB2	.	nonsynonymous SNV	PRB2:NM_006248:exon3:c.G326A:p.R109Q	2.88E-14	0.009733594	0.990266406	.	.	.	1.932845308	97.48171739	718.49848	5.3211	.	.	.	0.092	0.237	B	0.002	0.063	B	.	.	.	1	0.090	P	-1.265	0.007	N	3.71	0.041	T	-0.04	0.076	N	0.093	0.092	-0.976	0.359	T	0.003	0.010	T	.	.	.	-0.596	0.050	0.128	0.427	0.031	0.000	0.003	N	c	-2.034	-2.056	0.000	0.042	0.554	0.246	0	-2.46	0.061	-2.259	0.013	-0.819	0.031	0.000	0.063	0.001	0.043	2.776	0.050	.	.	.	0.5	95	145	chr12	11546686	chr12:11546686	C	T	95	PASS	AN=2;DP=145	GT	0/1
chr13	19393304	19393304	C	G	ncRNA_exonic	ANKRD20A9P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	81	chr13	19393304	chr13:19393304	C	G	71	PASS	AN=2;DP=81	GT	0/1
chr13	26620924	26620924	G	A	exonic	SHISA2	.	synonymous SNV	SHISA2:NM_001007538:exon2:c.C615T:p.N205N	0.404087524	0.557503271	0.038409205	.	0.3978	0.10893	.	.	1189.34167	6.54035	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	20	chr13	26620924	chr13:26620924	G	A	62	PASS	AN=2;DP=20	GT	0/1
chr13	32360691	32360691	-	AA	intronic	RXFP2	.	.	.	2.94E-08	0.978811653	0.021188317	.	0.16562	0.12616	-0.176292081	40.56381222	1150.99694	6.46394	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	19	chr13	32360691	chr13:32360691	T	TAA	42	PASS	AN=2;DP=19	GT	0/1
chr14	21762978	21762978	G	A	intronic	RPGRIP1	.	.	.	2.57E-21	0.046731913	0.953268087	DISEASE: Leber congenital amaurosis 6 (LCA6) [MIM:613826]: A severe dystrophy of the retina, typically becoming evident in the first years of life. Visual function is usually poor and often accompanied by nystagmus, sluggish or near-absent pupillary responses, photophobia, high hyperopia and keratoconus. {ECO:0000269|PubMed:11528500, ECO:0000269|PubMed:18682808}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cone-rod dystrophy 13 (CORD13) [MIM:608194]: An inherited retinal dystrophy characterized by retinal pigment deposits visible on fundus examination, predominantly in the macular region, and initial loss of cone photoreceptors followed by rod degeneration. This leads to decreased visual acuity and sensitivity in the central visual field, followed by loss of peripheral vision. Severe loss of vision occurs earlier than in retinitis pigmentosa. {ECO:0000269|PubMed:10958648, ECO:0000269|PubMed:12920076}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Heterozygous non-synonymous variants of RPGRIP1 may cause or increase the susceptibility to various forms of glaucoma, a genetically heterogeneous disorder. It is the second cause of blindness worldwide owing to the progressive degeneration of retinal ganglion neurons (PubMed:21224891). {ECO:0000269|PubMed:21224891}.; 	0.0819	0.1823	1.298854499	93.91365888	2951.663	10.29586	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	38	chr14	21762978	chr14:21762978	G	A	42	PASS	AN=2;DP=38	GT	0/1
chr14	23874506	23874506	C	A	exonic	MYH6	.	nonsynonymous SNV	MYH6:NM_002471:exon5:c.G428T:p.R143L	1.28E-17	0.998347117	0.001652883	DISEASE: Atrial septal defect 3 (ASD3) [MIM:614089]: A congenital heart malformation characterized by incomplete closure of the wall between the atria resulting in blood flow from the left to the right atria. {ECO:0000269|PubMed:15735645}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, familial hypertrophic 14 (CMH14) [MIM:613251]: A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death. {ECO:0000269|PubMed:11815426, ECO:0000269|PubMed:15998695}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, dilated 1EE (CMD1EE) [MIM:613252]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. {ECO:0000269|PubMed:15998695}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Sick sinus syndrome 3 (SSS3) [MIM:614090]: The term 'sick sinus syndrome' encompasses a variety of conditions caused by sinus node dysfunction. The most common clinical manifestations are syncope, presyncope, dizziness, and fatigue. Electrocardiogram typically shows sinus bradycardia, sinus arrest, and/or sinoatrial block. Episodes of atrial tachycardias coexisting with sinus bradycardia ('tachycardia-bradycardia syndrome') are also common in this disorder. SSS occurs most often in the elderly associated with underlying heart disease or previous cardiac surgery, but can also occur in the fetus, infant, or child without heart disease or other contributing factors. {ECO:0000269|PubMed:21378987}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. The lifetime risk of being diagnosed with sick sinus syndrome is higher for carriers of variant p.Arg721Trp than for non-carriers. {ECO:0000269|PubMed:21378987}.; 	0.84563	0.11625	-2.784931854	0.660533145	5098.77916	14.63955	0.001	0.784	D	0.718	0.403	P	0.589	0.486	P	.	.	.	1.000	0.499	D	1.495	0.376	L	-2.32	0.878	D	-4.74	0.801	D	0.866	0.853	0.601	0.919	D	0.714	0.902	D	0.171	0.849	D	6.311	0.872	29.2	0.998	0.913	0.981	0.791	D	c	0.534	0.531	1.000	0.747	0.447	0.083	0	4.41	0.524	5.895	0.693	0.839	0.342	1.000	0.715	1.000	0.888	17.184	0.867	Myosin head, motor domain|P-loop containing nucleoside triphosphate hydrolase	.	.	0.5	73	154	chr14	23874506	chr14:23874506	C	A	73	PASS	AN=2;DP=154	GT	0/1
chr14	105412138	105412138	A	G	exonic	AHNAK2	.	nonsynonymous SNV	AHNAK2:NM_001350929:exon7:c.T9350C:p.L3117P,AHNAK2:NM_138420:exon7:c.T9650C:p.L3217P	.	.	.	.	0.0478	.	27.59634509	99.99410238	24654.11397	32.49932	0.114	0.286	T	0.0	0.026	B	0.0	0.013	B	.	.	.	1	0.090	P	-2.045	0.002	N	6.64	0.005	T	2.0	0.004	N	0.055	0.037	-1.036	0.187	T	0.001	0.002	T	.	.	.	0.084	0.102	3.433	0.304	0.017	0.001	0.005	N	c	-1.613	-1.536	0.000	0.061	0.476	0.093	0	2.59	0.300	-0.281	0.084	-0.582	0.045	0.000	0.063	0.000	0.016	5.350	0.152	.	.	.	0.5	65	60	chr14	105412138	chr14:105412138	A	G	65	PASS	AN=2;DP=60	GT	0/1
chr14	107083633	107083633	T	C	intergenic	LINC00221;MIR7641-2	dist=132104;dist=9083	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	65	chr14	107083633	chr14:107083633	T	C	64	PASS	AN=2;DP=65	GT	0/1
chr14	107114193	107114193	A	G	intergenic	MIR7641-2;MIR5195	dist=21428;dist=144907	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	118	chr14	107114193	chr14:107114193	A	G	59	PASS	AN=2;DP=118	GT	0/1
chr15	25432640	25432640	G	T	ncRNA_intronic	SNHG14	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	82	15	chr15	25432640	chr15:25432640	G	T	82	PASS	AN=2;DP=15	GT	1/0
chr15	78271392	78271394	TGG	-	intergenic	LOC645752;LOC91450	dist=52204;dist=14181	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	112	38	chr15	78271391	chr15:78271391	CTGG	C	112	PASS	AN=2;DP=38	GT	0/1
chr15	102315105	102315105	C	T	intergenic	LOC100128108;OR4F6	dist=28032;dist=30818	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	38	chr15	102315105	chr15:102315105	C	T	61	PASS	AN=2;DP=38	GT	0/1
chr16	1260386	1260386	C	A	exonic	CACNA1H	.	nonsynonymous SNV	CACNA1H:NM_001005407:exon19:c.C3862A:p.Q1288K,CACNA1H:NM_021098:exon19:c.C3862A:p.Q1288K	0.755916976	0.244083023	1.19E-09	DISEASE: Epilepsy, idiopathic generalized 6 (EIG6) [MIM:611942]: A disorder characterized by recurring generalized seizures in the absence of detectable brain lesions and/or metabolic abnormalities. Generalized seizures arise diffusely and simultaneously from both hemispheres of the brain. {ECO:0000269|PubMed:15048902}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Epilepsy, childhood absence 6 (ECA6) [MIM:611942]: A subtype of idiopathic generalized epilepsy characterized by an onset at age 6-7 years, frequent absence seizures (several per day) and bilateral, synchronous, symmetric 3-Hz spike waves on EEG. Tonic-clonic seizures often develop in adolescence. Absence seizures may either remit or persist into adulthood. {ECO:0000269|PubMed:12891677}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.1215	0.15825	-2.059460781	1.627742392	3476.91536	11.35078	0.098	0.308	T	0.003	0.228	B	0.009	0.225	B	0.000	0.629	D	0.994	0.421	D	3.1	0.878	M	-4.11	0.967	D	-2.36	0.521	N	0.208	0.612	0.677	0.929	D	0.821	0.940	D	0.232	0.884	D	2.348	0.343	18.48	0.903	0.189	0.989	0.877	D	c	-0.104	-0.038	1.000	0.500	0.696	0.567	0	3.75	0.421	5.883	0.693	0.798	0.323	1.000	0.715	0.219	0.221	15.057	0.715	.	.	.	0.5	62	94	chr16	1260386	chr16:1260386	C	A	62	PASS	AN=2;DP=94	GT	0/1
chr16	2235420	2235420	A	C	intronic	CASKIN1	.	.	.	0.999956295	4.37E-05	1.04E-12	.	0.23556	0.11347	.	.	504.89212	4.61185	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	42	chr16	2235420	chr16:2235420	A	C	.	PASS	AN=0;DP=42	GT	0/1
chr16	88017809	88017809	C	T	exonic	BANP	.	synonymous SNV	BANP:NM_001173539:exon4:c.C306T:p.V102V,BANP:NM_001173540:exon4:c.C324T:p.V108V,BANP:NM_001173541:exon4:c.C306T:p.V102V,BANP:NM_001173542:exon4:c.C306T:p.V102V,BANP:NM_001173543:exon4:c.C282T:p.V94V,BANP:NM_017869:exon4:c.C306T:p.V102V,BANP:NM_079837:exon4:c.C306T:p.V102V	0.958647668	0.041348352	3.98E-06	.	0.64532	0.13415	-0.822919685	11.76574664	798.42168	5.56845	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	52	52	chr16	88017809	chr16:88017809	C	T	52	PASS	AN=2;DP=52	GT	0/1
chr17	37070646	37070646	G	A	exonic	LASP1	.	synonymous SNV	LASP1:NM_001271608:exon4:c.G258A:p.E86E,LASP1:NM_006148:exon5:c.G426A:p.E142E	0.866739435	0.132870174	0.000390391	.	0.33295	0.11829	-0.449946534	24.00330267	12.83432	0.46825	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	50	chr17	37070646	chr17:37070646	G	A	42	PASS	AN=2;DP=50	GT	0/1
chr17	48277042	48277042	C	A	intronic	COL1A1	.	.	.	0.999999999	1.02E-09	2.21E-25	DISEASE: Caffey disease (CAFFD) [MIM:114000]: Characterized by an infantile episode of massive subperiosteal new bone formation that typically involves the diaphyses of the long bones, mandible, and clavicles. The involved bones may also appear inflamed, with painful swelling and systemic fever often accompanying the illness. The bone changes usually begin before 5 months of age and resolve before 2 years of age. {ECO:0000269|PubMed:15864348}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ehlers-Danlos syndrome, classic type (EDS) [MIM:130000]: A connective tissue disorder characterized by hyperextensible skin, atrophic cutaneous scars due to tissue fragility and joint hyperlaxity. {ECO:0000269|PubMed:10739762, ECO:0000269|PubMed:17211858}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ehlers-Danlos syndrome 7A (EDS7A) [MIM:130060]: A connective tissue disorder characterized by hyperextensible skin, atrophic cutaneous scars due to tissue fragility and joint hyperlaxity. Marked by bilateral congenital hip dislocation, hyperlaxity of the joints, and recurrent partial dislocations. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteogenesis imperfecta 1 (OI1) [MIM:166200]: An autosomal dominant form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI1 is a non-deforming form with normal height or mild short stature, and no dentinogenesis imperfecta. {ECO:0000269|PubMed:1634225, ECO:0000269|PubMed:16638323, ECO:0000269|PubMed:16705691, ECO:0000269|PubMed:16786509, ECO:0000269|PubMed:1718984, ECO:0000269|PubMed:1737847, ECO:0000269|PubMed:17875077, ECO:0000269|PubMed:18670065, ECO:0000269|PubMed:24682174, ECO:0000269|PubMed:2794057, ECO:0000269|PubMed:3244312, ECO:0000269|PubMed:8223589}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteogenesis imperfecta 2 (OI2) [MIM:166210]: An autosomal dominant form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI2 is characterized by bone fragility, with many perinatal fractures, severe bowing of long bones, undermineralization, and death in the perinatal period due to respiratory insufficiency. {ECO:0000269|PubMed:10627137, ECO:0000269|PubMed:1460047, ECO:0000269|PubMed:1511982, ECO:0000269|PubMed:1613761, ECO:0000269|PubMed:16566045, ECO:0000269|PubMed:16786509, ECO:0000269|PubMed:18670065, ECO:0000269|PubMed:1874719, ECO:0000269|PubMed:18996919, ECO:0000269|PubMed:1939261, ECO:0000269|PubMed:1953667, ECO:0000269|PubMed:2035536, ECO:0000269|PubMed:2036375, ECO:0000269|PubMed:2037280, ECO:0000269|PubMed:2116413, ECO:0000269|PubMed:2211725, ECO:0000269|PubMed:2339700, ECO:0000269|PubMed:2470760, ECO:0000269|PubMed:25958000, ECO:0000269|PubMed:2777764, ECO:0000269|PubMed:2794057, ECO:0000269|PubMed:2913053, ECO:0000269|PubMed:3016737, ECO:0000269|PubMed:3108247, ECO:0000269|PubMed:3403550, ECO:0000269|PubMed:3667599, ECO:0000269|PubMed:7520724, ECO:0000269|PubMed:7679635, ECO:0000269|PubMed:7691343, ECO:0000269|PubMed:7961597, ECO:0000269|PubMed:8100209, ECO:0000269|PubMed:8349697, ECO:0000269|PubMed:8349698, ECO:0000269|PubMed:8364588, ECO:0000269|PubMed:8456808, ECO:0000269|PubMed:8786074, ECO:0000269|PubMed:9143923, ECO:0000269|Ref.47, ECO:0000269|Ref.50}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteogenesis imperfecta 3 (OI3) [MIM:259420]: An autosomal dominant form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI3 is characterized by progressively deforming bones, very short stature, a triangular face, severe scoliosis, grayish sclera and dentinogenesis imperfecta. {ECO:0000269|PubMed:10408781, ECO:0000269|PubMed:16879195, ECO:0000269|PubMed:1770532, ECO:0000269|PubMed:18670065, ECO:0000269|PubMed:2037280, ECO:0000269|PubMed:2511192, ECO:0000269|PubMed:2794057, ECO:0000269|PubMed:7691343, ECO:0000269|PubMed:7881420, ECO:0000269|PubMed:8019571, ECO:0000269|PubMed:8364588, ECO:0000269|PubMed:8456809, ECO:0000269|PubMed:8669434, ECO:0000269|PubMed:8723681, ECO:0000269|PubMed:9101304}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteogenesis imperfecta 4 (OI4) [MIM:166220]: An autosomal dominant form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI4 is characterized by moderately short stature, mild to moderate scoliosis, grayish or white sclera and dentinogenesis imperfecta. {ECO:0000269|PubMed:16786509, ECO:0000269|PubMed:16879195, ECO:0000269|PubMed:1770532, ECO:0000269|PubMed:17875077, ECO:0000269|PubMed:1988452, ECO:0000269|PubMed:2745420, ECO:0000269|PubMed:7691343, ECO:0000269|PubMed:7982948, ECO:0000269|PubMed:8094076, ECO:0000269|PubMed:8339541, ECO:0000269|PubMed:9600458}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteoporosis (OSTEOP) [MIM:166710]: A systemic skeletal disorder characterized by decreased bone mass and deterioration of bone microarchitecture without alteration in the composition of bone. The result is fragile bones and an increased risk of fractures, even after minimal trauma. Osteoporosis is a chronic condition of multifactorial etiology and is usually clinically silent until a fracture occurs. {ECO:0000269|PubMed:8841196, ECO:0000269|PubMed:9535665}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Note=A chromosomal aberration involving COL1A1 is found in dermatofibrosarcoma protuberans. Translocation t(17;22)(q22;q13) with PDGF.; 	0.99194	0.99087	-1.785892633	2.25878745	137.3096	2.54895	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	19	chr17	48277042	chr17:48277042	C	A	74	PASS	AN=2;DP=19	GT	0/1
chr17	61615660	61615660	-	G	intronic	KCNH6	.	.	.	3.94E-17	0.010222186	0.989777814	.	0.29959	0.16889	-0.606336534	17.51002595	660.24764	5.15277	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	45	14	chr17	61615660	chr17:61615660	T	TG	45	PASS	AN=2;DP=14	GT	0/1
chr17	73620205	73620205	G	C	intronic	MYO15B	.	.	.	.	.	.	.	0.14983	0.11459	.	.	4109.50851	12.72624	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	46	chr17	73620205	chr17:73620205	G	C	.	PASS	AN=0;DP=46	GT	0/1
chr17	79220110	79220110	C	-	exonic	SLC38A10	.	frameshift deletion	SLC38A10:NM_001037984:exon16:c.2606delG:p.G869Afs*38	4.09E-08	0.986554606	0.013445353	.	0.11386	0.09454	1.13164289	92.23873555	8935.42464	20.45812	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	49	54	chr17	79220109	chr17:79220109	GC	G	49	PASS	AN=2;DP=54	GT	0/1
chr17	80377690	80377690	T	G	exonic	HEXDC	.	synonymous SNV	HEXDC:NM_001330542:exon2:c.T15G:p.T5T,HEXDC:NM_173620:exon2:c.T15G:p.T5T	1.59E-06	0.854020781	0.145977631	.	0.1403	.	0.560331224	81.70559094	113.59821	2.32178	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	77	29	chr17	80377690	chr17:80377690	T	G	77	PASS	AN=2;DP=29	GT	0/1
chr18	77227476	77227476	A	G	exonic	NFATC1	.	synonymous SNV	NFATC1:NM_001278673:exon7:c.A570G:p.P190P,NFATC1:NM_172388:exon7:c.A570G:p.P190P,NFATC1:NM_001278669:exon8:c.A1986G:p.P662P,NFATC1:NM_001278670:exon8:c.A1986G:p.P662P,NFATC1:NM_001278672:exon8:c.A1947G:p.P649P,NFATC1:NM_001278675:exon8:c.A1947G:p.P649P,NFATC1:NM_006162:exon8:c.A1986G:p.P662P,NFATC1:NM_172387:exon8:c.A1947G:p.P649P,NFATC1:NM_172389:exon8:c.A1947G:p.P649P,NFATC1:NM_172390:exon8:c.A1986G:p.P662P	0.969219888	0.030779726	3.86E-07	.	0.26703	0.65916	-1.846676608	2.052370842	1895.12903	8.00523	.	.	.	.	.	.	.	.	.	.	.	.	1.000	0.588	P	.	.	.	2.5	0.144	T	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-0.835	0.039	0.036	0.251	0.011	0.012	0.043	N	n	-0.140	2.150	1.000	0.747	0.707	0.730	0	-9.38	0.005	-4.079	0.003	-6.217	0.000	0.000	0.063	0.044	0.160	5.332	0.151	.	.	.	0.5	51	41	chr18	77227476	chr18:77227476	A	G	51	PASS	AN=2;DP=41	GT	0/1
chr19	5787234	5787234	C	T	intronic	DUS3L	.	.	.	2.45E-09	0.447364589	0.552635408	.	0.16355	.	-0.685180376	15.32200991	3219.59367	10.81274	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	89	chr19	5787234	chr19:5787234	C	T	75	PASS	AN=2;DP=89	GT	0/1
chr19	8200817	8200817	C	T	intronic	FBN3	.	.	.	1.35E-27	0.999811749	0.000188251	.	0.09923	0.13532	7.067302466	99.89384289	18901.16442	29.48902	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	58	chr19	8200817	chr19:8200817	C	T	69	PASS	AN=2;DP=58	GT	0/1
chr19	8200926	8200926	G	T	exonic	FBN3	.	nonsynonymous SNV	FBN3:NM_001321431:exon13:c.C1510A:p.R504S,FBN3:NM_032447:exon13:c.C1510A:p.R504S	1.35E-27	0.999811749	0.000188251	.	0.09923	0.13532	7.067302466	99.89384289	18901.16442	29.48902	0.004	0.654	D	0.998	0.715	D	0.97	0.706	D	0.000	0.629	U	0.987	0.406	D	1	0.253	L	-2.86	0.914	D	-5.04	0.826	D	0.767	0.760	0.324	0.879	D	0.677	0.888	D	0.124	0.806	D	6.588	0.906	31	0.998	0.861	0.780	0.381	D	c	0.361	0.367	1.000	0.747	0.650	0.456	0	4.35	0.513	5.247	0.650	0.884	0.388	1.000	0.715	0.216	0.221	16.882	0.859	EGF-like calcium-binding domain|EGF-like calcium-binding, conserved site|EGF-like domain|Growth factor receptor cysteine-rich domain	.	.	0.5	60	122	chr19	8200926	chr19:8200926	G	T	60	PASS	AN=2;DP=122	GT	0/1
chr19	18700047	18700047	A	G	intronic	C19orf60	.	.	.	0.249879078	0.642082143	0.10803878	.	0.11766	.	.	.	32.748	1.01722	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	48	chr19	18700047	chr19:18700047	A	G	84	PASS	AN=2;DP=48	GT	0/1
chr19	50912139	50912139	G	A	exonic	POLD1	.	nonsynonymous SNV	POLD1:NM_001308632:exon14:c.G1951A:p.G651R,POLD1:NM_001256849:exon15:c.G1873A:p.G625R,POLD1:NM_002691:exon15:c.G1873A:p.G625R	0.001807011	0.998149838	4.32E-05	DISEASE: Colorectal cancer 10 (CRCS10) [MIM:612591]: A complex disease characterized by malignant lesions arising from the inner wall of the large intestine (the colon) and the rectum. Genetic alterations are often associated with progression from premalignant lesion (adenoma) to invasive adenocarcinoma. Risk factors for cancer of the colon and rectum include colon polyps, long-standing ulcerative colitis, and genetic family history. {ECO:0000269|PubMed:23263490, ECO:0000269|PubMed:24501277}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome (MDPL) [MIM:615381]: An autosomal dominant systemic disorder characterized by prominent loss of subcutaneous fat, metabolic abnormalities including insulin resistance and diabetes mellitus, sclerodermatous skin, and a facial appearance characterized by mandibular hypoplasia. Sensorineural deafness occurs late in the first or second decades of life. {ECO:0000269|PubMed:23770608}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.96379	0.4561	-0.828637633	11.54163718	551.71434	4.7781	0.226	0.185	T	0.177	0.273	B	0.052	0.241	B	0.016	0.281	N	1.000	0.548	D	2.18	0.615	M	2.36	0.161	T	-2.45	0.535	N	0.663	0.674	-1.111	0.030	T	0.047	0.200	T	0.023	0.464	T	4.438	0.594	24.2	0.898	0.185	0.940	0.596	D	c	-0.075	0.005	0.923	0.267	0.707	0.730	0	4.69	0.584	5.751	0.681	1.048	0.713	1.000	0.715	0.011	0.114	16.771	0.853	DNA-directed DNA polymerase, family B, multifunctional domain	.	.	0.5	84	51	chr19	50912139	chr19:50912139	G	A	84	PASS	AN=2;DP=51	GT	0/1
chr19	50978722	50978722	G	T	exonic	FAM71E1	.	synonymous SNV	FAM71E1:NM_001308429:exon3:c.C399A:p.L133L	0.006132393	0.737056923	0.256810684	.	0.18198	.	0.194852702	67.03231894	119.58351	2.38015	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	26	chr19	50978722	chr19:50978722	G	T	.	PASS	AN=0;DP=26	GT	0/1
chr19	53393473	53393473	C	G	intronic	ZNF320	.	.	.	0.018449658	0.961147618	0.020402724	.	0.12591	0.09845	-0.291981272	33.20358575	51.19238	1.41059	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	75	95	chr19	53393473	chr19:53393473	C	G	75	PASS	AN=2;DP=95	GT	0/1
chr19	53418644	53418644	-	GG	intronic	ZNF888	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	108	52	chr19	53418644	chr19:53418644	A	AGG	108	PASS	AN=2;DP=52	GT	0/1
chr19	56029168	56029168	C	T	exonic	SSC5D	.	synonymous SNV	SSC5D:NM_001144950:exon14:c.C3525T:p.F1175F	0.346968714	0.48487348	0.168157806	.	.	.	3.778595825	99.61665487	7583.62392	18.68079	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	35	chr19	56029168	chr19:56029168	C	T	62	PASS	AN=2;DP=35	GT	0/1
chr19	56029175	56029192	ACCCCTCACCCCACCACG	-	exonic	SSC5D	.	nonframeshift deletion	SSC5D:NM_001144950:exon14:c.3532_3549del:p.T1184_T1189del	0.346968714	0.48487348	0.168157806	.	.	.	3.778595825	99.61665487	7583.62392	18.68079	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	76	84	chr19	56029174	chr19:56029174	CACCCCTCACCCCACCACG	C	76	PASS	AN=2;DP=84	GT	0/1
chr20	29638007	29638007	T	A	ncRNA_exonic	MLLT10P1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	92	128	chr20	29638007	chr20:29638007	T	A	92	PASS	AN=2;DP=128	GT	0/1
chr20	44528543	44528543	G	A	intronic	PLTP	.	.	.	0.000142042	0.962665909	0.037192049	.	0.36337	0.21599	-0.440847477	24.59896202	193.00501	3.01119	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	53	chr20	44528543	chr20:44528543	G	A	72	PASS	AN=2;DP=53	GT	0/1
chr21	11058353	11058353	T	C	intronic	BAGE;BAGE2;BAGE3;BAGE4;BAGE5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	105	106	chr21	11058353	chr21:11058353	T	C	105	PASS	AN=2;DP=106	GT	0/1
chr21	33069024	33069024	-	TTCTGGCTCATCATCATAGTCAAATCTATCAAGCAACTTCTTTTTTAATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCTTGAATTCTGGAATAATTATGTCAATATTTCATTTTAAAATTTAGACTGA	exonic	SCAF4	.	stopgain	SCAF4:NM_001145444:exon7:c.771_772insTCAGTCTAAATTTTAAAATGAAATATTGACATAATTATTCCAGAATTCAAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGTAGATCTCGGTGGTCGCCGTATCATTAAAAAAGAAGTTGCTTGATAGATTTGACTATGATGATGAGCCAGAA:p.A258_R1132delinsSV,SCAF4:NM_001145445:exon8:c.816_817insTCAGTCTAAATTTTAAAATGAAATATTGACATAATTATTCCAGAATTCAAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGTAGATCTCGGTGGTCGCCGTATCATTAAAAAAGAAGTTGCTTGATAGATTTGACTATGATGATGAGCCAGAA:p.A273_R1125delinsSV,SCAF4:NM_020706:exon8:c.816_817insTCAGTCTAAATTTTAAAATGAAATATTGACATAATTATTCCAGAATTCAAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGTAGATCTCGGTGGTCGCCGTATCATTAAAAAAGAAGTTGCTTGATAGATTTGACTATGATGATGAGCCAGAA:p.A273_R1147delinsSV	0.999999693	3.07E-07	5.92E-18	.	0.7639	0.10408	-1.214341017	5.67940552	104.06406	2.20474	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	154	chr21	33069024	chr21:33069024	C	CTTCTGGCTCATCATCATAGTCAAATCTATCAAGCAACTTCTTTTTTAATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCTTGAATTCTGGAATAATTATGTCAATATTTCATTTTAAAATTTAGACTGA,CACCATTGTTAGTTTTTTTT	43	PASS	AN=2;DP=154	GT	0/1
chr21	33069024	33069024	-	ACCATTGTTAGTTTTTTTT	exonic	SCAF4	.	stopgain	SCAF4:NM_001145444:exon7:c.771_772insAAAAAAAACTAACAATGGT:p.A258Kfs*3,SCAF4:NM_001145445:exon8:c.816_817insAAAAAAAACTAACAATGGT:p.A273Kfs*3,SCAF4:NM_020706:exon8:c.816_817insAAAAAAAACTAACAATGGT:p.A273Kfs*3	0.999999693	3.07E-07	5.92E-18	.	0.7639	0.10408	-1.214341017	5.67940552	104.06406	2.20474	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	154	chr21	33069024	chr21:33069024	C	CTTCTGGCTCATCATCATAGTCAAATCTATCAAGCAACTTCTTTTTTAATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCTTGAATTCTGGAATAATTATGTCAATATTTCATTTTAAAATTTAGACTGA,CACCATTGTTAGTTTTTTTT	43	PASS	AN=2;DP=154	GT	0/1
chr21	38639638	38639638	C	-	UTR5	DSCR3	NM_001331018:c.-43delG;NM_001331021:c.-43delG;NM_001331022:c.-43delG;NM_006052:c.-43delG	.	.	0.505918972	0.489971529	0.004109499	.	0.14303	0.12016	-0.26993514	34.59542345	28.95913	0.9253	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	120	chr21	38639637	chr21:38639637	AC	A	80	PASS	AN=2;DP=120	GT	0/1
chr22	25574407	25574407	A	G	intronic	KIAA1671	.	.	.	.	.	.	.	.	.	.	.	239.04669	3.34052	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	55	chr22	25574407	chr22:25574407	A	G	74	PASS	AN=2;DP=55	GT	0/1
chrX	48324646	48324646	G	C	exonic	SLC38A5	.	nonsynonymous SNV	SLC38A5:NM_033518:exon7:c.C383G:p.A128G	0.976708482	0.023268194	2.33E-05	.	0.07584	0.24156	-0.359940251	28.93371078	343.94842	3.93203	0.287	0.176	T	0.056	0.214	B	0.101	0.292	B	0.000	0.629	D	1.000	0.588	D	1.215	0.307	L	4.32	0.024	T	-1.4	0.372	N	0.348	0.409	-0.840	0.527	T	0.008	0.030	T	0.013	0.316	T	0.455	0.138	7.080	0.959	0.275	0.927	0.560	D	.	.	.	1.000	0.747	.	.	.	3.83	0.431	4.515	0.600	0.055	0.163	1.000	0.715	0.179	0.212	9.913	0.404	Amino acid transporter, transmembrane domain	.	.	0.5	70	131	chrX	48324646	chrX:48324646	G	C	70	PASS	AN=2;DP=131	GT	0/1
chrX	133119384	133119386	CGG	-	exonic	GPC3	.	nonframeshift deletion	GPC3:NM_001164617:exon1:c.91_93del:p.P31del,GPC3:NM_001164618:exon1:c.91_93del:p.P31del,GPC3:NM_001164619:exon1:c.91_93del:p.P31del,GPC3:NM_004484:exon1:c.91_93del:p.P31del	0.987985909	0.01200951	4.58E-06	.	0.78059	0.36196	-0.448125345	24.19202642	61.55096	1.59866	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	49	39	chrX	133119383	chrX:133119383	CCGG	C	49	PASS	AN=2;DP=39	GT	0/1
chrX	151909156	151909156	A	G	exonic	CSAG1	.	nonsynonymous SNV	CSAG1:NM_001102576:exon4:c.A185G:p.K62R,CSAG1:NM_153478:exon5:c.A185G:p.K62R	0.000227012	0.30598978	0.693783208	.	0.01704	.	0.924227736	89.61429582	714.31094	5.30676	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.000	0.070	.	.	.	0.837	0.180	1.014	0.293	0.296	0.270	0.001	0.137	0.003	0.074	.	.	.	.	.	0.5	87	47	chrX	151909156	chrX:151909156	A	G	87	PASS	AN=2;DP=47	GT	0/1
